Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Nicotine Polacrilex Patent Expiration

Nicotine Polacrilex was first introduced by Haleon Us Holdings Llc in its drug Nicorette on Feb 9, 1996. Another drug containing Nicotine Polacrilex is Nicorette (Mint). 13 different companies have introduced drugs containing Nicotine Polacrilex.


Nicotine Polacrilex Patents

Given below is the list of patents protecting Nicotine Polacrilex, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nicorette US8323683 Flavoring of drug-containing chewing gums Apr 30, 2028 Haleon Us Holdings
Nicorette US8501164 Nicotine lozenge compositions Jun 14, 2029 Haleon Us Holdings
Nicorette US8940772 Nicotine lozenge composition Apr 30, 2029 Haleon Us Holdings



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Nicotine Polacrilex Generics

Several generic applications have been filed for Nicotine Polacrilex. The first generic version for Nicotine Polacrilex was by P And L Development Llc and was approved on Mar 15, 1999. And the latest generic version is by Fertin Pharma As and was approved on Dec 21, 2022.

Given below is the list of companies who have filed for Nicotine Polacrilex generic.


1. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE troche/lozenge Over the counter ORAL N/A Aug 3, 2021
EQ 4MG BASE troche/lozenge Over the counter ORAL N/A Aug 3, 2021


2. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE troche/lozenge Over the counter ORAL N/A May 13, 2022
EQ 4MG BASE troche/lozenge Over the counter ORAL N/A May 13, 2022


3. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE troche/lozenge Over the counter ORAL N/A Aug 4, 2020
EQ 4MG BASE troche/lozenge Over the counter ORAL N/A Aug 4, 2020


4. FERTIN PHARMA

Fertin Pharma As has filed for 1 generic for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Fertin Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE gum, chewing Discontinued BUCCAL N/A Dec 21, 2022


5. GLAXOSMITHKLINE CONS

Glaxosmithkline Consumer Healthcare has filed for 2 different strengths of generic version for Nicotine Polacrilex. All of these versions come by the name THRIVE. Given below are the details of the strengths of this generic introduced by Glaxosmithkline Cons.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE gum, chewing Discontinued BUCCAL N/A Jun 19, 2007
EQ 4MG BASE gum, chewing Discontinued BUCCAL N/A Jun 19, 2007


6. IVAX SUB TEVA PHARMS

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE gum, chewing Discontinued BUCCAL N/A Feb 18, 2009
EQ 4MG BASE gum, chewing Discontinued BUCCAL N/A Feb 18, 2009


7. L PERRIGO CO

L Perrigo Co has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by L Perrigo Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE gum, chewing Over the counter BUCCAL N/A Sep 16, 2004
EQ 2MG BASE gum, chewing Over the counter BUCCAL N/A Sep 16, 2004


8. P AND L

P And L Development Llc has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by P And L.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE troche/lozenge Over the counter ORAL N/A May 14, 2020
EQ 4MG BASE troche/lozenge Over the counter ORAL N/A May 14, 2020


9. PERRIGO R AND D

Perrigo R And D Co has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Perrigo R And D.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE gum, chewing Over the counter BUCCAL N/A Dec 15, 2016
EQ 2MG BASE gum, chewing Over the counter BUCCAL N/A Dec 15, 2016


10. PLD ACQUISITIONS

Pld Acquisitions Llc Dba Avema Pharma Solutions has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Pld Acquisitions.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE troche/lozenge Over the counter ORAL N/A Feb 7, 2019
EQ 2MG BASE troche/lozenge Over the counter ORAL N/A Feb 7, 2019


11. PPI-DAC

Perrigo Pharma International Dac has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Ppi-dac.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE troche/lozenge Over the counter ORAL N/A Oct 9, 2012
EQ 4MG BASE troche/lozenge Over the counter ORAL N/A Oct 9, 2012


12. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Nicotine Polacrilex. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE gum, chewing Discontinued BUCCAL N/A Jul 29, 2004
EQ 2MG BASE gum, chewing Discontinued BUCCAL N/A Jul 29, 2004